Skip to main content
. 2018 Jun 6;10(1):171–181. doi: 10.1111/jdi.12859

Figure 3.

Figure 3

Fibroblast growth factor (FGF)19 protein expressions by immunohistochemistry. Representative immunohistochemistry of FGF19 in the placenta and rectus muscle from women with gestational diabetes mellitus (GDM) (left column) and healthy pregnant women (control; right column). (a) GDM, placenta, FGF19 weak positive (+); (b) control, placenta, FGF19 strong positive (+++); (c) GDM, rectus muscle, FGF19 weak positive (+); (d) control, rectus muscle, FGF19 moderate positive (++); (e) GDM, subcutaneous fat, FGF19 negative (–); and (f) control, subcutaneous fat, FGF19 negative (–).